Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-2 + Optimized Antiretroviral Regimen in HIV-1 Patients with Treatment Failure
NCT00113282Phase 2Completed
- Sponsor
- ANRS
- Start
- Jun 2004
- Primary completion
- Dec 2007
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in human immunodeficiency virus infection (HIV), sponsored by ANRS. Started Jun 2004; status: completed.
02
Drugs
aldesleukin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00113282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00113282.